Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Eric P. Cohen MD
Professor
Department of Medicine
Division of Nephrology

OFFICE ADDRESS:
VA Medical Center
5000 W National Ave
Milwaukee, WI 53295

CITIZENSHIP:  U.S.A.

EDUCATION:
1973 - 1976 Candidat en Sciences Médicales, Université de Liège, Belgium
1976 - 1980 Docteur en Médecine, Université de Liège, Belgium

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
1980 - 1981 Internship, Internal Medicine, Tulane Affiliated Hospitals, New Orleans, LA
1981 - 1982 Resident, Internal Medicine, Tulane Affiliated Hospitals, New Orleans, LA
1982 - 1983 Resident in Neurology, University of Michigan Hospitals, Ann Arbor, MI
1983 - 1984 Resident, Internal Medicine, University of Chicago, Chicago, IL
1984 - 1986 Fellow in Nephrology, University of Chicago Program, Chicago, IL
1986 - 1987 Fellow in Nephrology, Northwestern University Program, Chicago, IL
1995 Visiting Fellow, University College London, London, England,

FACULTY APPOINTMENTS:
1987 - 1993 Assistant Professor of Medicine, Department of Medicine, Division of Nephrology, Medical College of Wisconsin, Milwaukee, WI
1993 - 2001 Associate Professor of Medicine, Department of Medicine, Divisoin of Nephrology, Medical College of Wisconsin, Milwaukee, WI
2001 - Present Professor of Medicine, Department of Medicine, Division of Nephology, Medical College of Wisconsin, Milwakee, WI
2012 - Present Professor of Radiology, Department of Radiology, Medical College of Wisconsin, Milwaukee, WI

ADMINISTRATIVE APPOINTMENTS:
1988 - 1994 Member and Chairman, Research Grant Committee, National Kidney Foundation of Wisconsin, WI
1989 - 1991 Member and Secretary, Executive Committee, Froedtert Hospital, Milwaukee, WI
1990 - 1993 Member, Quality Assurance Committee, Froedtert Hospital, Milwaukee, WI
1991 - 1994 Member, Admissions Committee , Medical College of Wisconsin, Milwaukee, WI
1992 - 1994 President, National Kidney Foundation of Wisconsin, WI
1994 Member, PreMedical Scholars Committee, Marquette University, Milwaukee, WI
1996 - 1999 Member, Curriculum Committee, Internal Medicine , Medical College of Wisconsin, Milwaukee, WI
1998 - 1999 Member, Chief of Urology Search Committee, Medical College of Wisconsin, Milwaukee, WI
1998 - 2001 Member, Library Committee, Medical College of Wisconsin, Milwaukee, WI
2002 - 2008 Member, Rank & Tenure Committee, Medical College of Wisconsin, Milwaukee, WI
2002 - 2009 Director, Nephrology Fellowship Program, Zablocki VA Medical Center, Milwaukee, WI
2002 - 2009 Director, Nephrology Fellowship Program, Medical College of Wisconsin, Milwaukee, WI
2003 - 2004 Member, Institutional Review Board, Froedtert Hospital, Milwaukee, WI
2003 Chairman, Internal Review Committee, Medical College of Wisconsin, Milwaukee, WI
2004 - 2007 Chairman, Rank and Tenure Committee, Medical College of Wisconsin, Milwaukee, WI
2005 - 2008 Medical Director , In-patient Dialysis Unit, Froedtert Hospital, Milwaukee, WI
2008 - Present Chief, Nephrology Section, Zablocki VA Medical Center, Milwaukee, WI
2009 - Present Chairman, Faculty Development Committee , Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
Internal Medicine
1984
None
Nephrology
1988
None
 
Licensure
Number Issue DateExpiration
Georgia License
023261
1981
11/30/2009
Wisconsin License
28331
1987
10/31/2009
 
AWARDS AND HONORS:
1976 - Present Candidat en Sciences Médicales, Avec Distinction
1980 - Present Docteur en Médecine, Avec Grande Distinction
1991 - Present Medical Volunteer of the Year, National Kidney Foundation of WI
1999 - Present Visiting Professor, University of Glasgow
2006 - Present Membre du Jury Comité de Thèse , Univ. de Liège
2009 - Present Co-promoteur de Thèse, Univ. de Liège
Top Doctor List, Milwaukee Magazine, 2008
Top Doctor List, Milwaukee Magazine, 2008

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
Radiation Research Society
Central Society for Clinical Research
Société Francophone de Dialyse
American Society of Nephrology
International Society of Nephrology
Radiation Research Society
American Society of Nephrology
Société Francophone de Dialyse
American Society of Nephrology
Radiation Research Society
Central Society for Clinical Research
Société Francophone de Dialyse
Central Society for Clinical Research

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorship
11/1994 Guest Editor, Festschrift Supplement to the Journal of the American Society of Nephrology
Editorial Board
1999 - 2001 American Journal of Kidney Diseases
1999 - 2004 Dialysis & Transplantation
2000 - 2002 Nephron
2004 - Present Kidney International
2004 - 2007 Advisory Board for Nephrology, Medscape
2008 - Present Nephron Clinical Practice

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1994 Abstract Review, Annual Meeting, American Society of Nephrology
1994 Session Chair, Annual Meeting, American Society of Nephrology
1998 Session Chair, Annual Meeting, Central Society for Clinical Research
1999 Abstract Review, Annual Meeting, American Society of Nephrology
2000 - 2002 Ad Hoc Reviewer, Study Section, NIH–NIA
2001 - 2003 Member, Government Relations Committee, American Society of Nephrology
2003 - 2006 Member, Policy and Pubic Affairs Committee, American Society of Nephrology
2005 - Present Named Expert, Renal Injury, NLM Radiological Event Medical Management Program, Department of Health and Human Services
2006 - 2009 Member, Chronic Kidney Disease Advisory Group, American Society of Nephrology
2008 Reviewer, Special Emphasis Panel, NIH-NIAID
2009 Abstract Review, Meeting, World Congress of Nephrology
2009 Reviewer, Wellcome Trust, England
2011 Reviewer, Special Emphasis Panel, NIH-NCI

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Prior
Peer Review
Title:
"Kidney Response to Radiation and Chemotherapy"
Source:
NIH/NCI (CA24652)
Role:
Collaborating Investigator
Dates:
1997 - 2002
Direct Funds:
$170,000
 
Title:
"Dietary sodium modulates radiation nephropathy"
Source:
American Heart Association
Role:
Principal Investigator
Dates:
2000 - 2002
Direct Funds:
$95,118
 
Source:
American Cancer Society
Role:
Principal Investigator
Dates:
2001
Direct Funds:
$74,115
 
Title:
"Kidney response to radiation and chemotherapy"
Source:
NIH/NCI (2 R01 CA024652-23A1)
Role:
Co-investigator
Dates:
2/5/2003 - 1/31/2007
Direct Funds:
$1,269,000
 
Title:
"Post-irradiation intervention to mitigate and treat non-hematological
Source:
NIH/NIAID 1U19AI067734-01
Role:
Co-investigator
Dates:
8/31/2005 - 7/31/2010
Direct Funds:
$2,799,952
 
Title:
"Deferiprone in radiation nephropathy"
Source:
NIH/NIAID U19AI067734
Role:
Principal Investigator
Dates:
8/1/2007 - 7/31/2008
Direct Funds:
$60,000
 
Title:
"Aldosterone in radiation nephropathy"
Source:
NIH/NIAID U19AI067734
Role:
Principal Investigator
Dates:
8/1/2008 - 7/31/2010
Direct Funds:
$200,000
 
INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
1. Nephrology Board Review, A.B.I.M. Recertification Course, Milwaukee, WI, 9/2000
2. Calcium Disorders, Nephrology Update, Waukesha, WI, 10/2002
3. Hyperparathyroidism, Grand Rounds, St. Mary's Hospital, Milwaukee, WI, 2/2004
 
Regional
1. Captopril in Experimental Radiation Nephropathy, Northwestern University, Chicago, IL, 3/1992
2. Fibrosis and Renal Failure, University of Iowa, Iowa City, IA, 2/1998
3. Experimental Radiation Nephropathy, University of Iowa, Iowa City, IA, 2/1998
4. BMT Nephropathy and Captopril Trial, Northwestern University, Chicago, IL, 11/1998
5. Polycystic kidney disease, Nephrology Symposium, S.I.U. Medical School, Springfield, IL, 5/2000
6. Grand Rounds – Renal Failure After Marrow Transplant, Minneapolis VA Medical Center, Minneapolis, MN, 10/2001
 
National
1. Direct Ads for Prescription Drugs, The Today Show, NBC TV, New York, NY, 6/1990
2. Acquired Renal Cysts, Polycystic Kidney Research Meeting, Kansas City, KS, 6/1992
3. Captopril in Experimental Radiation Nephropathy, Radiation Research Annual Meeting, Nashville, TN, 4/1994
4. Acquired Renal Cysts, Short Course, American Society of Nephrology Annual Meeting, New Orleans, LA, 11/1996
5. Hypertension After Marrow Transplant, Mini lecture, American Society of Nephrology Annual Meeting, Miami, FL, 11/1999
6. Stenosis of the Glomerulotubular Neck, Tufts University Medical School, Boston, MA, 12/1999
7. Site visit for NIH Program Project Grant proposal, Tufts University Medical School, Boston, MA, 7/2000
8. Holistic Approach to Dialysis Adequacy, 21st Annual Dialysis Meeting, New Orleans, LA, 2/2001
9. Uremic Itching, 21st Annual Dialysis Meeting, New Orleans, LA, 2/2001
10. Acute Renal Failure, Abbott Labs, Educational Series, Abbott Park, IL, 6/2001
11. Renal Failure After Marrow Transplant, Memorial Sloan Kettering Cancer Center, New York, NY, 3/2002
12. Hypertension in Chronic Hemodialysis, Centre de Rein Artificiel, Tassin, France, 5/13/2002
13. Renin-Angiotensin System in Radiation Nephropathy, Department of Physiology, Tulane University, New Orleans, LA, 10/2002
14. Beyond Uremia, Gambro Medical Directors, Las Vegas, NV, 4/2003
15. Parathyroidectomy in ESRD, SUNY Downstate, Nephrology Division, Brooklyn, NY, 8/2003
16. Parathyroidectomy in ESRD, American Society of Nephrology Annual Meeting, San Diego, CA, 11/2003
17. Urine Proteome in Radiation Nephropathy, AFRRI, Special Meeting, Bethesda, MD, 5/2008
 
International
1. Acquired Renal Cysts, University of Leicester, Leicester, England, 6/1992
2. Radiation Nephropathy, University of College London, London, England, 2/1995
3. Bone Marrow Transplant Nephropathy, Royal Free Hospital, London, England, 3/1995
4. Stenosis of the Glomerulotubular Neck, The Rayne Institute, London, England, 7/1995
5. Mechanisms of Radiation Nephropathy, International Radiation Research Meeting, Wurzburg, Germany, 9/1995
6. Tuffier and the First Remnant Kidney Model, University of College London, London, England, 11/1995
7. Bone Marrow Transplant Nephropathy, University of Glasgow, Glasgow, Scotland, 2/1999
8. Stenotic Glomerulotubular Necks and Renal Failure, University of Glasgow, Glasgow, Scotland, 2/1999
9. Radioation Nephropathy, Nephrology Forum, Boston, MA, 12/10/1999
10. Insuffisance Rénale Après Greffe de Moëlle, Université de Montréal, Hôpital Maisonneuve-Rosemont, Montréal, PQ, Canada, 11/13/2000
11. Insuffisance Rénale Après Greffe de Moëlle, Université de Genève, Centre de Radio-Oncologie, Genève, Switzerland, 5/15/2002
12. Renin, Receptors, and Radiation, Royal Free and UCL Medical School, London, England , 2/27/2003
13. Néphrite Radique, Université de Liège, Liège, Belgium, 9/26/2005 - 9/25/2005
14. BMT Nephropathy, 28th Japan Stem Cell Meeting, Tokyo, Japan, 3/24/2006
15. CKD and Cancer, K/DIGO Controversies, Amsterdam, Netherlands, 10/14/2006
16. CKD After BMT, University of Barcelona, Hospital Clinic, Barcelona, Spain, 9/13/2010
17. Mitigation of Radiation Nephropathy, ESTRO 29, Barcelona, Spain, 9/14/2010
 
COMMITTEE SERVICE:
Medical College
2002 - 2008 Member, Rank & Tenure Committee
2008 - 2009 Member, Research Affairs Committee
 
MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
1987 - 1998 Pathology Course, second year medical students, 1-4 hours yearly
1987 - 1998 Junior Syllabus, third year medical students, 6-10 hours yearly
1987 - Present Teaching rounds, fourth year medical students, 1-4 months yearly, as assigned
1996 - 1997 Physical exam preceptor, second year medical students
1999 Physical exam preceptor, second year medical students
2001 - 2002 Physical exam preceptor, second year medical students
2004 Department of Emergency Medicine Grand Rounds
2006 - 2008 Biochemistry course, M2 students, 2-4 hours, yearly
2007 - 2009 Pathology course, M2 students, 1-2 hours, yearly
2007 - Present Pathology Course, second year medical students, 1-4 hours yearly
 
Resident and Fellow Education
1989 Department of Medicine Grand Rounds
1991 Department of Medicine Grand Rounds
1992 - 1994 Department of Surgery Grand Rounds
1994 Department of Radiation Oncology Grand Rounds
1998 Department of Surgery Grand Rounds
1998 - 1999 Department of Medicine Grand Rounds
2001 Department of Surgery Grand Rounds
2002 Department of Radiation Oncology Grand Rounds
2002 Division of Cardiology Grand Rounds
2003 - 2006 Department of Medicine Grand Rounds
2005 - 2007 Division of Cardiology Grand Rounds
2006 Department of Emergency Medicine Grand Rounds
2008 Department of Radiation Oncology Grand Rounds
 
Postdoctoral Fellow Education
1997 - Present Nephrology fellow seminars 2-6 hours yearly
 
EXTRAMURAL TEACHING (e.g. at Marquette, UWM, etc.):
Continuing Medical Education
1996 - 2001 American Board of Internal Medicine, Contributor to Recertification Exam in Nephrology
 
MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Medical Students
Dr. Kevin Regner (MD 2001), Medical College of Wisconsin, 1998 - 2001
Dr. Melissa Joines (MD 2005), Medical College of Wisconsin, 2004
 
Graduate Students
MPh Committees
Dr. Nauman Siddiqi, Medical College of Wisconsin, 2004
Dr. Syed Hussain, Medical College of Wisconsin, 2007
 
Residents
Medical College of Wisconsin, Dr. Stewart Kolner
Medical College of Wisconsin, Dr. Chris M. Masi
Medical College of Wisconsin, Dr. Patricia Hill
Medical College of Wisconsin, Dr. Milan Jordan
Medical College of Wisconsin, Dr Kevin Regner
Medical College of Wisconsin, Dr P. Anthony Decker
Medical College of Wisconsin, Dr Syed Hussain
Medical College of Wisconsin, Dr Chinmaya Trivedi
Medical College of Wisconsin, Dr Brahm Vasudev
Medical College of Wisconsin, Dr. Puneet Sood
Medical College of Wisconsin, Dr. Ernest K. Sumaili
Medical College of Wisconsin, Amy Irving
Medical College of Wisconsin, Dr. William C. Elliott
Medical College of Wisconsin, Dr. Mark A. Matson
Medical College of Wisconsin, Dr. Steven G. Sievers
 
Faculty
Dr. Deane Charba, Medical College of Wisconsin, 2003
 
EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
Graduate Students
PhD Committees
Dr. Christophe Bovy, Université de Liège, 2006
 

BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Cohen E and Mogabgab, W. Ceftizoxime therapy of infection in hospitalized patients and comparison with cefamandol for urinary tract infections. J. Antimicrob. Chemoth. 10 (Suppl. C):253-2, 1982.
2. Cohen EP. Direct-to-the-public advertisement of prescription medication. N. Engl. J. Med. 318:373-376, 1988.
3. Batlle DC, Hizon M, Cohen E, Gutterman C , Gupta R. The use of the urinary anion gap in the diagnosis of hyperchloremic metabolic acidosis. N. Engl. J. Med. 318(10):594-599, 1988.
4. Cohen EP, Liu K, Batlle DC. Patterns of metabolic acidosis in patients with chronic renal failure: impact of hemodialysis. Int. J. Artif. Organs 11(6):440-448, 1988.
5. Taylor AJ, Cohen EP, Erickson SJ, Olson DL, Foley WD. Renal imaging in long-term dialysis patients: a comparison of CT and sonography. Am. J. Roentgenol. 153:765-767, 1989
6. Cohen EP and Elliott WC, Jr. The role of ischemia in acquired cystic kidney disease. Am. J. Kidney Dis. 15 (1): 55 -60, 1990.
7. Matson MA and Cohen, EP. Acquired cystic kidney disease: occurrence, prevalence, and renal cancers. Medicine. 69(4): 217-226, 1990.
8. Lawton CA, Cohen EP, Barber-Derus SW, Murray KJ, Ash RC, Casper JT, Moulder JE. Late renal dysfunction in adult survivors of bone marrow transplantation. Cancer 67(11): 2795-2800, 1991.
9. Cohen EP and Lemann J, Jr. The role of the laboratory in the evaluation of kidney function. Clin. Chem. 37: 785-796, 1991.
10. Sievers SG, Stack J, Piering WF, Cohen EP. Determinants of dialyzer reuseability. ASAIO Transactions 37:M185-M186, 1991.
11. Cohen EP, Sobrero M, Roxe DM, Levin ML. Reversibility of long standing urinary tract obstruction requiring chronic dialysis. Arch. Int. Med. 152: 177-179, 1992.
12. Cohen EP, Russell TJ, Garancis JC. Mast cells and calcium in severe uremic itching. Am. J. Med. Sci. 303 (6): 360-365, 1992.
13. Cohen EP, Bastani B, Cohen MR, Kolner S, Hemken P, Gluck SL. Absence of H+-ATPase in cortical collecting tubules of a patient with Sjogren's syndrome and distal renal tubular acidosis. J. Am. Soc. Nephrol. 3:264-271, 1992.
14. Lawton CA, Barber-Derus SW, Murray KJ, Cohen EP, Ash RC, Moulder JE. Influence of renal shielding on the incidence of late renal dysfunction associated with bone marrow transplantation in adult patients. Int. J. Radiat. Oncol. Biol. Phys. 23:681-686, 1992.
15. Masi CM, and Cohen EP. Dialysis efficacy and itching in renal failure. Nephron 62: 257-261, 1992.
16. Cohen EP, Fish BL, Moulder JE. Treatment of radiation nephropathy with captopril. Radiat. Res. 132:346-350, 1992.
17. Cohen EP, Lawton CA, Moulder JE, Becker CG, Ash RC. The clinical course of bone marrow transplant nephropathy. Nephron 64:626-635, 1993.
18. Cohen EP. Le prurit urémique. Néphrologie 14:215-219, 1993.
19. Moulder JE, Fish BL, Cohen EP. Treatment of radiation nephropathy with ACE inhibitors. Int. J. Radiat. Oncol. Biol. Phys. 27:93-99, 1993.
20. Moulder JE, Cohen EP, Fish BL, Hill P. Prophylaxis of bone marrow transplant nephropathy with captopril, an angiotensin converting enzyme inhibitor. Radiat.Res. 136: 404-407, 1993.
21. Sterns RH, Cappucio JD, Silver SM, Cohen EP. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J. Am. Soc. Nephrol. 4:1522-30, 1994.
22. Cohen EP, Moulder JE, Fish BL, Hill P. Prophylaxis of experimental bone marrow transplant nephropathy. J. Lab. Clin. Med., 124:371-380, 1994.
23. Cohen MR, Cohen EP. Enthesopathy and atypical gouty arthritis following renal transplantation: A case control study. Rev. Rheum. 2:86-90, 1995.
24. Cohen EP, Lawton CA, Moulder JE. Bone marrow transplant nephropathy - radiation nephritis revisited. Nephron 70:217-222, 1995.
25. Sarode R, McFarland JG, Flomenberg N, Casper JT, Cohen EP, et al. Therapeutic plasma
26. Exchange does not appear to be effective in the management of thrombotic thrombocytopenic
27. purpural hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow
28. Transplant 16: 271-275, 1995.
29. Cohen EP. Fibrosis causes progressive kidney failure. Medical Hypoth. 45:459-462, 1995.
30. Cohen EP, Lemann J, Jr. In hereditary nephritis angiotensin-converting enzyme inhibition decreases proteinuria and may slow the rate of progression. Am. J. Kidney Dis. 27:199-203, 1996.
31. Jordan M, Cohen EP, Roza A, Adams MB, Johnson C, Gluck SL, Bastani B. An immunocytochemical study of H+ATPase in kidney transplant rejection. J. Lab. Clin. Med. 127:310-4, 1996.
32. Cohen EP, Fish BL, Moulder JE. The role of nitric oxide in radiation nephropathy. Arch Physiol. Biochem. 104:200-206, 1996.
33. Cohen EP. L'hypertrophie rénale compensatrice: contributions de T. Tuffier et de P. Carnot. Néphrologie 17:255-259, 1996.
34. Moulder JE, Fish BL, Cohen EP, Bonsib SM. Angiotensin II receptor antagonists in the prevention of radiation nephropathy. Radiat. Res. 146:106-110, 1996.
35. Cohen EP, Molteni A, Hill P, Fish BL, Ward WF, Moulder JE, Carone FA. Captopril preserves function and ultrastructure in experimental radiation nephropathy. Lab. Invest. 75:349-360, 1996.
36. Wrong O, Unwin R, Cohen E, Tanner M, Thakker R. Unraveling of the molecular mechanisms of kidney stones. Grand Round. Lancet 348:1561-1565, 1996.
37. Moulder JE, Fish BL, Cohen EP. Noncontinuous use of angiotensin converting enzyme inhibitors in the treatment of experimental bone marrow transplant nephropathy. Bone Marrow Transplant. 19:729-735, 1997.
38. Cohen EP, Fish BL, Moulder JE. Successful brief captopril treatment in experimental radiation nephropathy. J. Lab. Clin. Med. 129:536-47, 1997.
39. Cohen EP, Robbins MEC, Whitehouse E, Hopewell JW. Stenosis of the tubular neck - a mechanism for progressive renal failure. J. Lab. Clin. Med.129:567-73, 1997.
40. Lawton CA. Cohen EP, Murray KJ, Derus SW, Moulder JE. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. Bone Marrow Transplant , 12:1069-1074, 1997.
41. Hariharan S, McBride M, Bennett LE, Cohen EP. Risk factors for renal allograft survival from older cadaver donors. Transplantation, 64:1748-1754, 1997.
42. Moulder JE, Fish BL, Cohen EP. Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type 1 receptor antagonist. Radioth Oncol, 46:307-315, 1998.
43. Cohen EP. Dialysis hypertension, dry weight, and dialysis time. Nephrol. Dial.Transplant, 13:554-555, 1998.
44. Cohen EP, Piering WF, Kabler-Babbitt C, Moulder JE. End-stage-renal-disease after bone marrow transplantation : poor survival compared to other causes of ESRD. Nephron, 79:408-412, 1998.
45. Cohen EP. Glomerulotubular neck stenosis: the link between interstitial scarring and reduced GFR? Nephrol. Dial. Transplan., 13:2961-2962,1998.
46. Moulder JE, Fish BL, Cohen EP. Brief pharmacologic intervention in experimental radiation nephropathy. Radiat Res, 150:535-541, 1998.
47. Datta PK, Moulder JE, Fish BL, Cohen EP, Lianos EA. TGFß1 production in radiation nephropathy : role of angiotensin II. Int J Radiat Biol, 75:473-479,1999.
48. Butcher JA, Hariharan S, Adams MB, Johnson CJ, Roza AM, Cohen EP. Renal transplantation for end stage renal disease following bone marrow transplantation. Clinical Transplantation, 13:330-335, 1999.
49. Cohen EP, Fish BL, Moulder JE. Angiotensin II infusion exacerbates radiation nephropathy. J Lab Clin Med, 134:283-91, 1999.
50. Cohen EP, Bonsib SA, Whitehouse E, Hopewell JW, Robbins MEC. Mediators and mechanisms of radiation nephropathy. Proc Soc Exper Biol Med, 223:218-225, 2000.
51. Molteni A, Moulder JE, Cohen EP, Ward WF, Fish BL, Taylor JM, Wolfe LM, Brizio-Molteni L, Veno P. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. Int J Radiat Biol 67:523-532, 2000.
52. Cohen EP. Radiation nephropathy after bone marrow transplantation. Kidney Int, 58:903-918, 2000.
53. Cohen EP, Regner K, Fish BL, Moulder JE. Stenotic glomerulotubular necks in radiation nephropathy. J Pathol, 190:484-488, 2000.
54. Decker PA, Cohen EP, Ashley BA, Bienneman ME, Zhu YR, Adams MB, Wilson SD, Demeure MJ. Subtotal parathyroidectomy in renal failure: Still needed after all these years. World J Surg 25:708-712, 2001
55. Ahuja M, Cohen EP, Dayer AM, Kampalath B, Chang CC, Bresnahan BA, Hariharan S Polyoma virus infection after renal transplantation : use of immunostaining as a guide to diagnosis. Transplantation, 71:896-9, 2001
56. MB Juckett, EP Cohen, CA Keever-Taylor, Y Zheng, CA Lawton, JE Moulder, J Klein. Loss of Renal Function following Bone Marrow Transplantation: An analysis of Angiotensin Converting Enzyme D/I Polymorphism and other Clinical Risk Factors. Bone Marrow Transplantation 27:451-456, 2001
57. Datta PK, Moulder JE, Fish BL, Cohen EP, Lianos EA. Induction of Heme Oxygenase 1 in Radiation Nephropathy: Role of Angiotensin II. Radiat Res 155: 734-739, 2001
58. Sharma M, Sharma R, Ge XL, Fish BL, McCarthy ET, Savin VJ, Cohen EP, Moulder JE. Early detection of radiation-induced glomerular injury by albumin permeability assay. Radiat Res, 155:474-480, 2001
59. Cohen EP, Moulder JE . Parathyroidectomy in chronic renal failure: has medical care reduced the need for surgery? Nephron 89:271-273, 2001
60. Molteni A, Moulder JE, Cohen EP, Fish BL, Taylor JM, Veno PA, Wolfe LF, Ward WF. Prevention of radiation induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II blocker. Exp Biol Med 226:1016-1023, 2001
61. Cohen EP, Fish BL, Moulder JE: The renin-angiotensin system in experimental radiation nephropathy. J Lab Clin Med 139: 251-257, 2002
62. Moulder JE, Fish BL, Regner KR, Cohen EP. Angiotensin II blockade reduces radiation induced proliferation in experimental radiation nephropathy. Radiat Res, 157:393-401, 2002
63. Moulder JE, Fish BL, Regner KR, Cohen EP, Raife TJ. Retinoic acid exacerbates radiation nephropathy. Radiat Res 157:199-203, 2002
64. Hussain S, Bresnahan BA, Cohen EP, Hariharan S. Rapid kidney allograft failure in patients with polyoma virus nephritis with prior treatment with antilymphocyte agents. Clin Transplant 2002 Feb;16(1):43-47
65. Moulder JE, Fish BL, Cohen EP. Dietary sodium modification and experimental radiation nephropathy. Int J Radiat Biol, 78:903-911, 2002
66. Cohen EP, Hussain S, Moulder JE. Successful treatment of radiation nephropathy with angiotensin II blockade. Int J Radiat Oncol Biol Physics, 55: 190-193, 2003
67. Cohen EP, Rosendale JD, Bong C, Hariharan S. The benefit of child-to-parent kidney donation. Am J Transplant 3:865-872, 2003
68. Hariharan S, McBride MA, Cohen EP. Evolution of endpoints for renal transplant outcome. Am J Transplant, 3:933-941, 2003
69. Moulder JE, Fish BL, Cohen EP Impact of angiotensin II type 2 receptor blockade on experimental radiation nephropathy. Radiat Res, 161, 312-317, 2004
70. Hussain S, Orentas R, Walczak J, Cohen EP, Hariharan, S. Prevention of BKV Nephritis by Monitoring BK Viremia in Renal Transplant Recipients: A Prospective Study. Graft 7: 28-30, 2004
71. Hariharan S, Cohen EP, Vasudev B, Orentas R, Kakela J, DuChateau B. BKV specific antibodies and BKV DNA in Renal Transplant Recipinets with BKV Nephritis, Am J Transplantation Vol 5:2719-2724, 2005
72. Vasudev B, Hariharan S, Hussain SA, Zhu YR, Bresnahan BA, Cohen EP. BK Virus Nephritis: Risk Factors, timing and outcome in Renal Transplant Recipients. Kidney International, Oct; 68(4):1834-9, 2005.
73. Sharma M, McCarthy ET, Sharma R, Fish BL, Savin VJ, Cohen EP, Moulder JE. Arachidonic Acid metabolites mediate the radiation - induced increase in glomerular albumin permeability. Exp Biol Med 231 (1): 99-106, 2006
74. Cohen EP, Fish BL, Sharma M, Li XA. Moulder JE. Role of the angiotensin II type 2 receptor in radiation nephropathy Translational Research 150: 106-115, 2007
75. Levey A, Atkins R, Cohen EP, Collins A, Coresh H, Eknoyan G, Eckhardt KU, El-Nahas M, Jaber B, Lameire N, Levin A, Powe N, Rossert J, Wheeler D. Chronic Kidney Disease as a Global Public Health Problem: Approach and Initiatives - A Position Statement from KDIGO. Kidney Int 72: 247-259, 2007
76. Sood P, Sinson GP, Cohen EP. Subdural hematomas in chronic dialysis patients: Significant and increasing. Clin J Am Soc Nephrol 2: 956-959, 2007
77. Cohen EP, Irving AA, Drobyski WR, Klein JP, Passweg J, Talano JM, Juckett MB, Moulder JE. Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. Int J Radiat Oncol Biol Phys, 70: 1546-1551, 2008
78. Prosser SE, Orentas RJ, Jurgens L, Cohen EP, Hariharan S. Recovery of BKV Large T antigen-specific cellular immune response correlates with resolution of BKV nephritis. Transplantation, 85: 185-192, 2008
79. Saad ER, Bresnahan BA, Cohen EP, et al. Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. Transplantation 85: 850-854, 2008
80. Sumaili EK, Krzesinski JM, Zinga CV, Cohen EP, Delanaye P, Munyanga SM, Nseka NM. Prevalence of chronic kidney disease in Kinshasa: Results of a pilot study from the Democratic Republic of Congo. Nephrol Dial Transplant, 2008, 24:117-122, 2009.
81. Delanaye P, Cohen EP. Formula based estimates of the GFR: equations variable and uncertain. Nephron Clin Prac, 2008, 110:c48-c53, 2008.
82. Lenarczyk M, Cohen EP, Fish BL, Irving AA, Sharma M, Driscoll CD, Moulder JE. Chronic oxidative stress as a mechanism for radiation nephropathy. Radiat. Res, 2008, 171: 164-172, 2009.
83. Sieber F, Muir SA, Cohen EP, North PE, Fish BL, Irving AA, Mäder M, Moulder JE. High-Dose Selenium for the Mitigation of Radiation Injury: A Pilot Study in a Rat Model. Radiat Res, 2008, 171: 368-373, 2009.
84. Hussain S, Piering W, Mohyuddin T, Saleh M, Zhu Y, Hannan M, Cohen EP. Outcome among patients with acute renal failure needing continuous renal replacement therapy: a single center study. Hemodialysis International 13: 1-10, 2009.
85. Cohen EP, Fish BL, Irving AA, Rajapurkar MM, Shah SV, Moulder JE. Radiation Nephropathy is not mitigated by antagonists of oxidative stress. Radiat. Res, 172:260-4, 2009
86. Sumaili EK, Cohen EP, Zinga CV, Krzesinski JM, Pakasa NM, Nseka NM. High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC Nephrol. 21;10-18. 2009
87. Sood P, Zhu YR, Cohen EP. Death with Functioning Kidney Transplant: An Obituarial Analysis. Int J Urol Nephrol 42:499-502, 2010
88. Sumaili EK, Krzesinski JM, Cohen EP, Nseka NM. Epidemiology of chronic kidney disease in the Democratic Republic of Congo: review of cross sectional studies from Kinshasa, the capital. Néphrol Thér 6:232-239, 2010
89. Moulder JE, Fish BL, Cohen EP. Captopril and losartan for mitigation of renal injury caused by single dose total body irradiation. Radiat Res, 175:29-36, 2011
90. Cohen EP, Bruder ED, Ziegler D, Cullinan WE, Raff H. The Effect of High Dose Total Body Irradiation on ACTH, Corticosterone, and Catecholamines in the Rat. Translational Research, 157:38-47, 2011
91. Raff H, Bruder ED, Cullinan WE, Ziegler DR, Cohen EP. Effect of animal facility construction on basal hypothalamic pituitary adrenal and renin-aldosterone activity in the rat. Endocrinology, 2011, in press
92. Cohen EP, Bastani B, Cohen MR, Kolner S, Hemken P, Gluck SL Absence of H(+)-ATPase in cortical collecting tubules of a patient with Sjogren's syndrome and distal renal tubular acidosis. J Am Soc Nephrol. 1992 Aug;3(2):264-71
93. Masi CM, Cohen EP Dialysis efficacy and itching in renal failure. Nephron. 1992;62(3):257-61
94. Cohen EP, Fish BL, Moulder JE Treatment of radiation nephropathy with captopril. Radiat Res. 1992 Dec;132(3):346-50
95. Cohen EP, Russell TJ, Garancis JC Mast cells and calcium in severe uremic itching. Am J Med Sci. 1992 Jun;303(6):360-5
96. Lawton CA, Barber-Derus SW, Murray KJ, Cohen EP, Ash RC, Moulder JE Influence of renal shielding on the incidence of late renal dysfunction associated with T-lymphocyte deplete bone marrow transplantation in adult patients. Int J Radiat Oncol Biol Phys. 1992;23(3):681-6
97. Cohen EP, Sobrero M, Roxe DM, Levin ML Reversibility of long-standing urinary tract obstruction requiring long-term dialysis. Arch Intern Med. 1992 Jan;152(1):177-9
98. Sievers SG, Stack JL, Piering WF, Cohen EP Determinants of dialyzer reuseability. ASAIO Trans. 1991 Jul-Sep;37(3):M185-6
99. Lawton CA, Cohen EP, Barber-Derus SW, Murray KJ, Ash RC, Casper JT, Moulder JE Late renal dysfunction in adult survivors of bone marrow transplantation. Cancer. 1991 Jun 1;67(11):2795-800
100. Cohen EP, Elliott WC Jr The role of ischemia in acquired cystic kidney disease. Am J Kidney Dis. 1990 Jan;15(1):55-60
101. Matson MA, Cohen EP Acquired cystic kidney disease: occurrence, prevalence, and renal cancers. Medicine (Baltimore). 1990 Jul;69(4):217-26
102. Taylor AJ, Cohen EP, Erickson SJ, Olson DL, Foley WD Renal imaging in long-term dialysis patients: a comparison of CT and sonography. AJR Am J Roentgenol. 1989 Oct;153(4):765-7
103. Cohen EP Direct-to-the-public advertisement of prescription drugs. N Engl J Med. 1988 Feb 11;318(6):373-6
104. Cohen EP, Lawton CA, Moulder JE Bone marrow transplant nephropathy: radiation nephritis revisited. Nephron. 1995;70(2):217-22
105. Sarode R, McFarland JG, Flomenberg N, Casper JT, Cohen EP, Drobyski WR, Ash RC, Horowitz MM, Camitta B, Lawton C Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant. 1995 Aug;16(2):271-5
106. Cohen MR, Cohen EP Enthesopathy and atypical gouty arthritis following renal transplantation: a case control study. Rev Rhum Engl Ed. 1995 Feb;62(2):86-90
107. Sterns RH, Cappuccio JD, Silver SM, Cohen EP Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol. 1994 Feb;4(8):1522-30
108. Cohen EP, Moulder JE, Fish BL, Hill P Prophylaxis of experimental bone marrow transplant nephropathy. J Lab Clin Med. 1994 Sep;124(3):371-80
109. Cohen EP [Uremic pruritus]. Nephrologie. 1993;14(5):215-9
110. Moulder JE, Cohen EP, Fish BL, Hill P Prophylaxis of bone marrow transplant nephropathy with captopril, an inhibitor of angiotensin-converting enzyme. Radiat Res. 1993 Dec;136(3):404-7
111. Moulder JE, Fish BL, Cohen EP Treatment of radiation nephropathy with ACE inhibitors. Int J Radiat Oncol Biol Phys. 1993 Sep 1;27(1):93-9
112. Cohen EP, Lawton CA, Moulder JE, Becker CG, Ash RC Clinical course of late-onset bone marrow transplant nephropathy. Nephron. 1993;64(4):626-35
113. Cohen EP, Lemann J Jr In hereditary nephritis angiotensin-converting enzyme inhibition decreases proteinuria and may slow the rate of progression. Am J Kidney Dis. 1996 Feb;27(2):199-203
114. Moulder JE, Fish BL, Cohen EP, Bonsib SM Angiotensin II receptor antagonists in the prevention of radiation nephropathy. Radiat Res. 1996 Jul;146(1):106-10
115. Cohen EP Fibrosis causes progressive kidney failure. Med Hypotheses. 1995 Nov;45(5):459-62
116. Cohen EP [Compensatory renal hypertrophy: contributions of T. Tuffier and P. Carnot]. Nephrologie. 1996;17(4):255-9
117. Cohen EP, Molteni A, Hill P, Fish BL, Ward WF, Moulder JE, Carone FA Captopril preserves function and ultrastructure in experimental radiation nephropathy. Lab Invest. 1996 Sep;75(3):349-60
118. Cohen EP, Fish BL, Moulder JE The role of nitric oxide in radiation nephropathy. Arch Physiol Biochem. 1996;104(2):200-6
119. Cohen EP, Fish BL, Moulder JE Successful brief captopril treatment in experimental radiation nephropathy. J Lab Clin Med. 1997 May;129(5):536-47
120. Cohen EP, Robbins ME, Whitehouse E, Hopewell JW Stenosis of the tubular neck: a possible mechanism for progressive renal failure. J Lab Clin Med. 1997 May;129(5):567-73
121. Moulder JE, Fish BL, Cohen EP Noncontinuous use of angiotensin converting enzyme inhibitors in the treatment of experimental bone marrow transplant nephropathy. Bone Marrow Transplant. 1997 Apr;19(7):729-35
122. Jordan M, Cohen EP, Roza A, Adams MB, Johnson C, Gluck SL, Bastani B An immunocytochemical study of H+ ATPase in kidney transplant rejection. J Lab Clin Med. 1996 Mar;127(3):310-4
123. Hariharan S, McBride MA, Bennett LE, Cohen EP Risk factors for renal allograft survival from older cadaver donors. Transplantation. 1997 Dec 27;64(12):1748-54
124. Lawton CA, Cohen EP, Murray KJ, Derus SW, Casper JT, Drobyski WR, Horowitz MM, Moulder JE Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. Bone Marrow Transplant. 1997 Dec;20(12):1069-74
125. Moulder JE, Robbins ME, Cohen EP, Hopewell JW, Ward WF Pharmacologic modification of radiation-induced late normal tissue injury. Cancer Treat Res. 1998;93:129-51
126. Cohen EP Dialysis hypertension: dry weight and dialysis time. Nephrol Dial Transplant. 1998 Mar;13(3):554-5
127. Moulder JE, Fish BL, Cohen EP Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonist. Radiother Oncol. 1998 Mar;46(3):307-15
128. Moulder JE, Fish BL, Cohen EP Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathy. Int J Radiat Biol. 1998 Apr;73(4):415-21
129. Cohen EP, Piering WF, Kabler-Babbitt C, Moulder JE End-stage renal disease (ESRD)after bone marrow transplantation: poor survival compar ed to other causes of ESRD. Nephron. 1998 Aug;79(4):408-12
130. Moulder JE, Fish BL, Cohen EP Brief pharmacological intervention in experimental radiation nephropathy. Radiat Res. 1998 Nov;150(5):535-41
131. Cohen EP Glomerulotubular neck stenosis: the link between interstitial scarring and reduced GFR? Nephrol Dial Transplant. 1998 Nov;13(11):2961-2
132. Datta PK, Moulder JE, Fish BL, Cohen EP, Lianos EA TGF-beta 1 production in radiation nephropathy: role of angiotensin II. Int J Radiat Biol. 1999 Apr;75(4):473-9
133. Cohen EP, Fish BL, Moulder JE Angiotensin II infusion exacerbates radiation nephropathy. J Lab Clin Med. 1999 Sep;134(3):283-91
134. Butcher JA, Hariharan S, Adams MB, Johnson CP, Roza AM, Cohen EP Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression. Clin Transplant. 1999 Aug;13(4):330-5
135. Cohen EP, Bonsib SA, Whitehouse E, Hopewell JW, Robbins ME Mediators and mechanisms of radiation nephropathy. Proc Soc Exp Biol Med. 2000 Feb;223(2):218-25
136. Cohen EP, Regner K, Fish BL, Moulder JE Stenotic glomerulotubular necks in radiation nephropathy. J Pathol. 2000 Mar;190(4):484-8
137. Cohen EP Radiation nephropathy after bone marrow transplantation. Kidney Int. 2000 Aug;58(2):903-18
138. Sharma M, Sharma R, Ge XL, Fish BL, McCarthy ET, Savin VJ, Cohen EP, Moulder JE Early detection of radiation-induced glomerular injury by albumin permeability assay. Radiat Res. 2001 Mar;155(3):474-80
139. Datta PK, Moulder JE, Fish BL, Cohen EP, Lianos EA Induction of heme oxygenase 1 in radiation nephropathy: role of angiotensin II. Radiat Res. 2001 May;155(5):734-9
140. Juckett MB, Cohen EP, Keever-Taylor CA, Zheng Y, Lawton CA, Moulder JE, Klein J Loss of renal function following bone marrow transplantation: an analysis of angiotensin converting enzyme D/I polymorphism and other clinical risk factors. Bone Marrow Transplant. 2001 Feb;27(4):451-6
141. Ahuja M, Cohen EP, Dayer AM, Kampalath B, Chang CC, Bresnahan BA, Hariharan S Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. Transplantation. 2001 Apr 15;71(7):896-9
142. Decker PA, Cohen EP, Doffek KM, Ashley BA, Bienemann ME, Zhu YR, Adams ME, Wilson SD, Demeure MJ Subtotal parathyroidectomy in renal failure: still needed after all these years. World J Surg. 2001 Jun;25(6):708-12
143. Cohen EP, Moulder JE Parathyroidectomy in chronic renal failure: has medical care reduced the need for surgery? Nephron. 2001 Nov;89(3):271-3
144. Molteni A, Moulder JE, Cohen EP, Fish BL, Taylor JM, Veno PA, Wolfe LF, Ward WF Prevention of radiation-induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II receptor blocker. Exp Biol Med (Maywood). 2001 Dec;226(11):1016-23
145. Moulder JE, Fish BL, Regner KR, Cohen EP, Raife TJ Retinoic acid exacerbates experimental radiation nephropathy. Radiat Res. 2002 Feb;157(2):199-203
146. Moulder JE, Fish BL, Regner KR, Cohen EP Angiotensin II blockade reduces radiation-induced proliferation in experimental radiation nephropathy. Radiat Res. 2002 Apr;157(4):393-401
147. Hussain S, Bresnahan BA, Cohen EP, Hariharan S Rapid kidney allograft failure in patients with polyoma virus nephritis with prior treatment with antilymphocyte agents. Clin Transplant. 2002 Feb;16(1):43-7
148. Cohen EP, Fish BL, Moulder JE The renin-angiotensin system in experimental radiation nephropathy. J Lab Clin Med. 2002 Apr;139(4):251-7
149. Moulder JE, Fish BL, Cohen EP Dietary sodium modification and experimental radiation nephropathy. Int J Radiat Biol. 2002 Oct;78(10):903-11
150. Cohen EP, Hussain S, Moulder JE Successful treatment of radiation nephropathy with angiotensin II blockade. Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):190-3
151. Moulder JE, Fish BL, Cohen EP ACE inhibitors and AII receptor antagonists in the treatment and prevention of bone marrow transplant nephropathy. Curr Pharm Des. 2003;9(9):737-49
152. Cohen EP, Rosendale JD, Bong CJ, Hariharan S Benefit of child-to-parent kidney donation. Am J Transplant. 2003 Jul;3(7):865-72
153. Hariharan S, McBride MA, Cohen EP Evolution of endpoints for renal transplant outcome. Am J Transplant. 2003 Aug;3(8):933-41
154. Ganne V, Siddiqi N, Kamaplath B, Chang CC, Cohen EP, Bresnahan BA, Hariharan S Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder. Clin Transplant. 2003 Oct;17(5):417-22
155. Moulder JE, Fish BL, Cohen EP Impact of angiotensin II type 2 receptor blockade on experimental radiation nephropathy. Radiat Res. 2004 Mar;161(3):312-7
156. Cohen EP, Moulder JE Parathyroidectomy in ESRD. Kidney Int. 2004 Jul;66(1):459; author reply 459
157. Cohen EP, Trivedi C Hypercalcaemia from non-prescription vitamin A. Nephrol Dial Transplant. 2004 Nov;19(11):2929
158. Vasudev B, Hariharan S, Hussain SA, Zhu YR, Bresnahan BA, Cohen EP BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients. Kidney Int. 2005 Oct;68(4):1834-9
159. Hariharan S, Cohen EP, Vasudev B, Orentas R, Viscidi RP, Kakela J, DuChateau B BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis. Am J Transplant. 2005 Nov;5(11):2719-24
160. Sharma M, McCarthy ET, Sharma R, Fish BL, Savin VJ, Cohen EP, Moulder JE Arachidonic acid metabolites mediate the radiation-induced increase in glomerular albumin permeability. Exp Biol Med (Maywood). 2006 Jan;231(1):99-106
161. Cohen EP, Drobyski WR, Moulder JE Significant increase in end-stage renal disease after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007 May;39(9):571-2
162. Cohen EP, Fish BL, Sharma M, Li XA, Moulder JE Role of the angiotensin II type-2 receptor in radiation nephropathy. Transl Res. 2007 Aug;150(2):106-15
163. Sood P, Sinson GP, Cohen EP Subdural hematomas in chronic dialysis patients: significant and increasing. Clin J Am Soc Nephrol. 2007 Sep;2(5):956-9
164. Cohen EP, Irving AA, Drobyski WR, Klein JP, Passweg J, Talano JA, Juckett MB, Moulder JE Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1546-51
165. Prosser SE, Orentas RJ, Jurgens L, Cohen EP, Hariharan S Recovery of BK virus large T-antigen-specific cellular immune response correlates with resolution of bk virus nephritis. Transplantation. 2008 Jan 27;85(2):185-92
166. Saad ER, Bresnahan BA, Cohen EP, Lu N, Orentas RJ, Vasudev B, Hariharan S Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. Transplantation. 2008 Mar 27;85(6):850-4
167. Sumaili EK, Krzesinski JM, Zinga CV, Cohen EP, Delanaye P, Munyanga SM, Nseka NM Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo. Nephrol Dial Transplant. 2009 Jan;24(1):117-22
168. Lenarczyk M, Cohen EP, Fish BL, Irving AA, Sharma M, Driscoll CD, Moulder JE Chronic oxidative stress as a mechanism for radiation nephropathy. Radiat Res. 2009 Feb;171(2):164-72
169. Sieber F, Muir SA, Cohen EP, North PE, Fish BL, Irving AA, Mäder M, Moulder JE High-dose selenium for the mitigation of radiation injury: a pilot study in a rat model. Radiat Res. 2009 Mar;171(3):368-73
170. Hussain SA, Cohen EP Outcomes of critically ill patients with acute kidney injury and end-stage renal disease requiring renal replacement therapy: a case-control study. Nephrol Dial Transplant. 2009 Jul;24(7):2290; author reply 2290-1
171. Sumaili EK, Cohen EP, Zinga CV, Krzesinski JM, Pakasa NM, Nseka NM High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC Nephrol. 2009;10:18
172. Cohen EP, Fish BL, Irving AA, Rajapurkar MM, Shah SV, Moulder JE Radiation nephropathy is not mitigated by antagonists of oxidative stress. Radiat Res. 2009 Aug;172(2):260-4
173. Sharma M, Halligan BD, Wakim BT, Savin VJ, Cohen EP, Moulder JE The Urine Proteome as a Biomarker of Radiation Injury: Submitted to Proteomics- Clinical Applications Special Issue: "Renal and Urinary Proteomics (Thongboonkerd)" Proteomics Clin Appl. 2008 Jun 18;2(7-8):1065-1086
174. Sharma M, Halligan BD, Wakim BT, Savin VJ, Cohen EP, Moulder JE The urine proteome for radiation biodosimetry: effect of total body vs. local kidney irradiation. Health Phys. 2010 Feb;98(2):186-95
175. Prasanna PG, Blakely WF, Bertho JM, Chute JP, Cohen EP, Goans RE, Grace MB, Lillis-Hearne PK, Lloyd DC, Lutgens LC, Meineke V, Ossetrova NI, Romanyukha A, Saba JD, Weisdorf DJ, Wojcik A, Yukihara EG, Pellmar TC Synopsis of partial-body radiation diagnostic biomarkers and medical management of radiation injury workshop. Radiat Res. 2010 Feb;173(2):245-53
176. Sumaili EK, Krzesinski JM, Cohen EP, Nseka NM [Epidemiology of chronic kidney disease in the Democratic Republic of Congo: review of cross-sectional studies from Kinshasa, the capital]. Nephrol Ther. 2010 Jul;6(4):232-9
177. Sood P, Zhu YR, Cohen EP Death with functioning kidney transplant: an obituarial analysis. Int Urol Nephrol. 2010 Dec;42(4):929-34
178. Cohen EP, Fish BL, Moulder JE Mitigation of radiation injuries via suppression of the renin-angiotensin system: emphasis on radiation nephropathy. Curr Drug Targets. 2010 Nov;11(11):1423-9
179. Moulder JE et al. Captopril and Losartan for Mitigation of Renal Injury Caused by Single-Dose Total-Body Irradiation. Radiat Res. 2010 Oct 26:
180. Cohen EP, Bruder ED, Cullinan WE, Ziegler D, Raff H Effect of high-dose total body irradiation on ACTH, corticosterone, and catecholamines in the rat. Transl Res. 2011 Jan;157(1):38-47
181. Moulder JE, Cohen EP, Fish BL Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation. Radiat Res. 2011 Jan;175(1):29-36
182. Raff H, Bruder ED, Cullinan WE, Ziegler DR, Cohen EP Effect of animal facility construction on basal hypothalamic-pituitary-adrenal and renin-aldosterone activity in the rat. Endocrinology. 2011 Apr;152(4):1218-21
183. Sieber F, Muir SA, Cohen EP, Fish BL, Mäder M, Schock AM, Althouse BJ, Moulder JE Dietary Selenium for the Mitigation of Radiation Injury: Effects of Selenium Dose Escalation and Timing of Supplementation. Radiat Res. 2011 Jul 8:
184. Sieber F, Muir SA, Cohen EP, Fish BL, Mäder M, Schock AM, Althouse BJ, Moulder JE Dietary selenium for the mitigation of radiation injury: effects of selenium dose escalation and timing of supplementation. Radiat Res. 2011 Sep;176(3):366-74
185. Vasudev M, Bresnahan BA, Cohen EP, Hari PN, Hariharan S, Vasudev BS Percussion hemoglobinuria - a novel term for hand trauma-induced mechanical hemolysis: a case report. J Med Case Rep. 2011;5:508
186. Cohen EP, Bedi M, Irving AA, Jacobs E, Tomic R, Klein J, Lawton CA, Moulder JE Mitigation of late renal and pulmonary injury after hematopoietic stem cell transplantation. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):292-6
187. Kharofa J, Cohen EP, Tomic R, Xiang Q, Gore E Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):238-43
188. Cohen SR, Cohen EP Chronic oxidative stress after irradiation: An unproven hypothesis. Med Hypotheses. 2013 Feb;80(2):172-5
189. Cohen EP, Irving AA, Drobyski WR, Klein JP, Passweg J, Talano JA, Juckett MB, Moulder JE Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1546-51
190. Bukabau JB, Makulo JR, Pakasa NM, Cohen EP, Lepira FB, Kayembe PK, Nseka NM, Sumaili EK Chronic kidney disease among high school students of Kinshasa. BMC Nephrol. 2012;13:24
191. Sharma A, Fish BL, Moulder JE, Medhora M, Baker JE, Mader M, Cohen EP Safety and blood sample volume and quality of a refined retro-orbital bleeding technique in rats using a lateral approach. Lab Anim (NY). 2014 Jan 22;43(2):63-6
 
Books, Chapters, and Reviews
1. Cohen E.P. Prescription drugs should not be advertised. Chemical Dependency, Chapter 26, pp. 105-107. Leone et al., Eds. Greenhaven Press, San Diego, CA. 1989.
2. Cohen, E.P. Are pharmaceutical ads good medicine? Bus. Soc. Rev. 73: 8-10, 1990.
3. Cohen E.P. Direct-to-consumer ads for prescription medication. Bioethics Bulletin. 4 (3): 4-5, 1991.
4. Cohen E.P. Acquired Cystic Kidney Disease. Urology/Nephrology 4:9-10, 1991.
5. Brandes JC, Cohen EP. An easy method for estimation of the protein catabolic rate. Seminars in Dialysis. 4(3):205, 1991.
6. Cohen EP. Epidemiology of acquired cystic kidney disease. Proc. 5th International Polycystic Kidney Research Foundation Meeting, Kansas City, MO, June 1992. PKR Foundation, Kansas City, MO, 1993.
7. Cohen EP, Pan C. Renal cystic disease. In : Current Nephrology, volume 17, chapter 7 Mosby-Year Book, St. Louis, MO, 1994.
8. Cohen EP. Prescription drug advertising is harmful. In: Drug Abuse: opposing viewpoints, Chapter 4, Bender D and Leone B, eds. Greenhaven Press, San Diego, 1994.
9. Cohen EP. Beyond adequacy - incentive for excellence. Contemp. Dial. Nephrol. 16:21-23, 1995.
10. Cohen EP. Tissue mechanisms of radiation nephropathy. In: Radiation Research 1895- 1995, U. Hagen, D. Harder, H. Jung, C. Streffer, eds. Universitätsdruckerei H. Stürtz AG, vol. 2, Wurzburg.
11. Cohen EP. Acquired Renal Cystic Disease. In: Polycystic Kidney Disease. Watson, M. and Torres, V. eds. Oxford University Press, 1996.
12. Cohen EP, Lawton CA. Pathogenesis, prevention, and Management of Radiation Nephropathy. In: Current Radiation Oncology, vol. 3, Tobias JS and Thomas PRM, eds., E. Arnold Ltd., 1997.
13. Moulder JE, Robbins MEC, Cohen EP, Hopewell JW, Ward WF. Pharmacologic modification of radiation-induced normal tissue injury. In: Radiation Therapy, BB Mittal, JA Purdy, LL Ang, eds. Kluwer Academic Publishers, 1998.
14. Moulder JE, Fish BL, Cohen EP. Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathy. Int J Radiat Biol, 73:415-421, 1998.
15. Cohen EP. Alport syndrome - a special case of hereditary nephropathy. Saudi J Kidney Dis Transplant, 10:1-6, 1999.
16. Cohen EP. Radiation nephritis. In http://www.eMedicine.com.
17. Cohen EP. Chronic renal failure and dialysis. In Scientific American Medicine, Dale DC, and Federman DD, eds, chapter 10, section ten, book 3, 2000.
18. Cohen EP. Acute renal failure after bone marrow transplantation. In Acute Renal Failure,
19. Molitoris B, and Finn W, eds, WB Saunders, Philadelphia 2001.
20. Cohen EP. Renal failure after bone marrow transplantation. Lancet 357:6-7, 2001
21. Cohen EP. Kidney damage from pamidronate. International Myeloma Foundation. Newsletter 2002, 4:5, 13
22. Cohen EP. Stenosis of the glomerulotubular neck. Nephron, 92:259-262, 2002
23. Lindop GBM, Gibson IW, Downie TT, Vass D, Cohen EP. The glomerulo-tubular junction: a target in renal diseases. J Pathol, 197:1-3, 2002
24. Moulder JE, Fish BL, Cohen EP. ACE inhibitors and AII receptor blockers in the treatment and prevention of bone marrow transplant nephropathy. Current Pharm Design, 9:737-749, 2003
25. Cohen EP. Fluid,electrolyte, and acid-base disorders. In Kochar's Concise Textbook Medicine, third edition, Williams and Wilkins, Baltimore, 2003
26. Cohen EP. Radiation nephropathy, in Oxford Textbook of Clinical Nephrology, 2005.
27. Cohen EP, Robbins MEC. Radiation nephropathy. Semin Nephrol, 23:486-499, 2003
28. Cohen EP. Cardiovascular disease, anemia, and chronic kidney disease in Medscape, 2002,
29. www.medscape.com
30. Cohen EP. Management of severe secondary hyperparathyroidism, in Medscape, 2003, www.medscape.com
31. Coulange C, Rambaud J.J. Jaqmin D, Cohen E, Amiel J. Le cancer du rein de l'adulte,
32. Rev Med Suisse Romande, 124:669-674, 2004
33. Cohen EP, editor, Cancer and the Kidney, Oxford University Press, 2005
34. Cohen EP. Cardiorenal anemia syndrome in Medscape, 2005, www.medscape.com
35. Cohen EP, Joines MM, Moulder JE. Prevention and Treatment of Radiation Injuries - The role of the Renin-angiotensin System, in Late effects of cancer treatment in normal tissues. Rubin P, et al, eds, Springer, Berlin, 2008
36. JE Moulder, EP Cohen: Radiation-induced multi-organ involvement and failure: The contribution of radiation effects of the renal system. Brit J Radiol Supplement 27: 82-88, 2005
37. Cohen EP: Priorities in dialysis care in Medscape, www.medscape.com, 2005
38. Kobori H, Ozawa Y, Suzaki Y, Prieto-Carrasquero MC, Nishiyama A, Shoji T, Cohen EP, Navar LG. Young Scholars Award Lecture: Intratubular angiotensionogen in hypertension and kidney diseases. Am J Hypertension, 19: 541-550, 2006
39. Cohen EP. International Dialysis outcomes and Practice Pattern Studies (DOPPS): improving outcomes in altered mineral metabolism and vascular access in Medscape, 2005, www.medscape.com
40. Krzesinski JM, Sumaili EK, Cohen E. How to tackle the avalanche of Chronic kidney disease in sub-Saharan Africa. The situation in the Democratic Republic of Congo as an example. Nephrol Dial Transpl, 22: 332-335, 2007
41. Cohen, EP. Alternatives to conventional hemodialysis: Home dialysis and intensive dialsysis therapies in Medscape, 2007, www.medscape.com
42. Krzesinski JM, Cohen EP. Hypertension and the kidney Acta. Clin. Belgica, 62: 405-414, 2006
43. Moulder JE, Fish BL, Cohen EP. Treatment of radiation nephropathy with ACE inhibitors and AAII type 1 and type 2 antagonists. Curr Pharm Design, 13: 1317-1325, 2007
44. Cohen EP, Krzesinski JM. La physiopathologie de l' hypertension artérielle en dialyse chronique. Nephrol. Et Therap. 3: S152-S157, 2007
45. Saad ER, Cohen EP, Shames BD. Transplantation or dialysis for patients who have end-stage renal disease with heart failure. Transplant. Rev. 21: 171-176, 2007.
46. Krzesinski JM, Cohen EP. Salt, the kidneys, and hypertension. Acta Clin Belgica, 62: 346-355, 2007.
47. Cohen EP. Membrane Fluidity and Polycystic Kidney Disease: A Hypothesis. Nephron Physiology, 108: 8-10, 2008.
48. Cohen EP. Vitamin D and cardiovascular risk in Medscape, 2008 www.medscape.com
49. Krzesinski JM, Cohen EP. Le phosphore est-il un facteur de risque cardiovasculaire. Performance Medicales, Realites Cardiologiques,, 254: Fevrier, 2009.
50. Krzesinski JM, Cohen EP. Exforge (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact. Core Evidence 3:117-126, 2008.
51. Cohen EP. Bone disease in dialysis. Medscape Congress report, 2008, www.medscape.com.
52. Prasanna PGS, Blakely WF, Bertho JM, et al. Synopsis of partial body radiation diagnostic biomarkers and medical management of radiation injury workshop. Radiat Res, 173:245-253, 2010
53. Cohen EP, Krzesinski JM. C-reactive protein and hemodialysis access. Kidney Int, 76:1025-6, 2009
54. Cohen EP, Pais P, Moulder JE. Chronic kidney disease after hematopoietic stem cell transplantation. Semin Nephrol, 30:627-634, 2010 PMCID: PMC3005300
55. Cohen EP, Fish BL, Moulder JE. Mitigation of Radiation Injuries via Suppression of the Renin-Angiotensin system: Emphasis on Radiation Nephropathy, Curr Drug Targets, 2010, in press
56. Cohen EP. Nephrotic Syndrome. eMedicine from WebMD. Updated December 20, 2010. Available at: http://emedicine.medscape.com/article/244631-overview.
57. Cohen EP, Moulder JE. Radiation, cancer, and kidneys: a look at risk. ASN Kidney News 3:15, 2011
58. Cohen EP, Lemann J Jr The role of the laboratory in evaluation of kidney function. Clin Chem. 1991 Jun;37(6):785-96
59. Cohen EP, Robbins ME Radiation nephropathy. Semin Nephrol. 2003 Sep;23(5):486-99
60. Cohen EP Stenosis of the glomerulotubular neck. Nephron. 2002 Oct;92(2):259-62
61. Moulder JE, Cohen EP Radiation-induced multi-organ involvement and failure: the contribution of radiation effects on the renal system. BJR Suppl. 2005;27:82-8
62. Kobori H, Ozawa Y, Suzaki Y, Prieto-Carrasquero MC, Nishiyama A, Shoji T, Cohen EP, Navar LG Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases. Am J Hypertens. 2006 May;19(5):541-50
63. Moulder JE, Cohen EP Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Semin Radiat Oncol. 2007 Apr;17(2):141-8
64. Krzesinski JM, Cohen EP Hypertension and the kidney. Acta Clin Belg. 2007 Jan-Feb;62(1):5-14
65. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007 Aug;72(3):247-59
66. Moulder JE, Fish BL, Cohen EP Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonists. Curr Pharm Des. 2007;13(13):1317-25
67. Krzesinski JM, Cohen EP Salt, the kidneys, and arterial hypertension. Acta Clin Belg. 2007 Sep-Oct;62(5):348-57
68. Cohen EP, Krzesinski JM [The physiopathology of dialysis-associated hypertension]. Nephrol Ther. 2007 Oct;3 Suppl 3:S150-5
69. Delanaye P, Cohen EP Formula-based estimates of the GFR: equations variable and uncertain. Nephron Clin Pract. 2008;110(1):c48-53; discussion c54
70. Krzesinski JM, Cohen EP Exforge (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact. Core Evid. 2010;4:1-11
71. Cohen EP, Pais P, Moulder JE Chronic kidney disease after hematopoietic stem cell transplantation. Semin Nephrol. 2010 Nov;30(6):627-34
 
Editorials, Letters to Editor, Other
1. Cohen, E.P. Advertising of prescription drugs. N. Engl. J. Med. 319(5):314-315, 1988.
2. Batlle, D.C., Hizon, M., Cohen, E., Gutterman, C. and Gupta, R. Urinary anion gap in hyperchloremic metabolic acidosis. N. Engl. J. Med. 319(9):585-587, 1988.
3. Cohen, E.P. Risks of breaking drug-ad taboo. Wall Street Journal. May 8, 1989, p. A15.
4. Cohen, E.P. Renal cystic disease (book review) N. Engl. J. Med. 320(22):1502-1503, 1989.
5. Cohen E.P., Lemann J. Jr. More on S.I. units. N. Engl. J. Med. 327 (1):51, 1992.
6. Cohen E.P. The Acid Truth and Basic Facts (book review). JAMA 268:543-544,1992.
7. Cohen E.P. Do we need another cooperative Dialysis Study? Sem. Dialysis 6:324-325, 1993.
8. Cohen, E.P. Predictors of mortality in patients undergoing hemodialysis. N. Engl. J. Med., 330:573, 1994.
9. Cohen EP, Mutsaers SE. Size matters. Nature 379:765, 1996.
10. Cohen EP. Fluids and electrolytes. (book review) JAMA 276:1527-1528, 1996.
11. Cohen EP. Understanding acid-base (book review) JAMA, 280: 1872, 1998.
12. Cohen EP. Beyond Uremia : hemodialysis at the millennium. Dial. Transplant., 29: 125-128, 2000.
13. Cohen EP. Hypertension in chronic hemodialysis: viewing a paradox and some notes on therapy. Dial. Transplant., 29:535-542, 2000.
14. Cohen EP, Moulder JE, Robbins MEC. Radiation nephropathy caused by Yttrium 90. Lancet 358:1102-1103, 2001
15. Cohen EP. Wholistic dialysis care: setting priorities straight. Dial Transplant 30: 680-683, 2001
16. Cohen EP. Cost versus benefit of vitamin D analogues for treatment of secondary hyperparathyroidism. Dial Transplant, 31:828-830, 2002
17. Cohen EP, Moulder JE. Parathyroidectomy in ESRD. Kidney Int. 66:459, 2004
18. Cohen EP. The need for parathyroidectomy. Nephrol Dial Transplant, 19:2417, 2004
19. Cohen EP, Trivedi C. Hypercalcemia from non-prescription vitamin A. Nephrol Dial Transplant, 19:2929, 2004
20. Cohen EP. The hidden price tag for health care. NY Times, Dec 19, 2004
21. Cohen EP, Charba DC. Home hemodialysis cannot be advocated for all patients. Nephrol. Dial Transplant, 20: 1272, 2005
22. Cohen EP, Uribarri J. Cinacalcet: a cost commentary. Semin. Dial. 18:353-354, 2005
23. Cohen EP. Don't overlook benefits of medical spending. Milwaukee Journal-Sentinel,
24. May 8, 2005
25. Moulder JE, Cohen EP. Renal dysfunction after total body irradiation: dose-effect relationship.
26. International Journal of Radiation Oncology, Biology, Physics. 67:319, 2007
27. Cohen EP, Drobyski W, Moulder JE. Significant increase in ESRD after hematopoietic cell
28. Transplantation. Bone Marrow Transplant, 39: 571-572, 2007
29. Cohen EP. Cinacalcet: benefit and cost. Nephrol Dial Transplant, 23: 1460, 2008
30. Cohen EP. Acquired cystic disease of the kidney and renal cell carcinoma (book review).
31. Nephrol Dial Transplant, 23: 406, 2008
32. Cohen EP. HIPAA threatens clinical research. Ann. Diagn. Pathol., 12: 311-312, 2008.
33. Hussain SA, Cohen EP. Outcomes of critically ill patients with acute kidney injury and end-stage renal disease requiring renal replacement therapy, a case control study. Nephrol Dial Transpl, 24:2290, 2009
34. Sumaili EK, Cohen EP. Screening for chronic kidney disease in sub-Saharan Africa. Lancet 376:418, 2010
35. Cohen EP. Management of acute kidney problems (book review). J Amer Med Assoc 304:1497-1498, 2010
36. Cohen EP, Moulder JE. Radiation risk to dialysis patients. Kidney Int, 79:686, 2011
37. CA Lawton, EP Cohen, JE Moulder: Kidney and adrenal toxicity. In: Human Radiation Injury (DC Shrieve, JS Loeffler, Eds.). Lippincott Williams & Wilkins, Philadelphia, 2010, pp. 328-339.
38. Moulder JE, Fish BL, Cohen EP, Klein JP. Letter to the editor. Re: Davis et al. ''Timing of Captopril Administration Determines Radiation Protection or Radiation Sensitization in a Murine Model of Total Body Irradiation.'' Exp Hematol. 2011;39:293-304.
39. Cohen EP. Tenth man. Temple Bulletin, Waukesha, Wisconsin, Fall 1999
40. Cohen EP. Shoes. The Grapevine, Department of Medicine, Medical College of Wisconsin, March 2001
41. Cohen EP. A Wisconsin First. Milwaukee Acad. Medicine Bulletin, December 2002, pp 4-5
42. Cohen EP. Death in Belgium. Milwaukee Acad. Medicine Bulletin, February 2003, p 3
43. Cohen EP. Research subject. Hektoen Int, 2010, in press
44. Cohen EP, Lemann J Jr More on SI units. N Engl J Med. 1992 Jul 2;327(1):51; author reply 52
45. Cohen EP Predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1994 Feb 24;330(8):573; author reply 573-4
46. Cohen EP, Moulder JE, Robbins ME Radiation nephropathy caused by yttrium 90. Lancet. 2001 Sep 29;358(9287):1102-3
47. Cohen EP Renal failure after bone-marrow transplantation. Lancet. 2001 Jan 6;357(9249):6-7
48. Lindop GB, Gibson IW, Downie TT, Vass D, Cohen EP The glomerulo-tubular junction: a target in renal diseases. J Pathol. 2002 May;197(1):1-3
49. Moulder JE, Cohen EP Renal dysfunction after total body irradiation: dose-effect relationship: in regard to Kal and van Kempen-Harteveld (Int J Radiat Oncol Biol Phys 2006;65:1228-1232). Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):319; author reply 319-20
50. Cohen EP Membrane fluidity and polycystic kidney disease: a hypothesis. Nephron Physiol. 2008;108(1):p8-10
51. Cohen EP HIPAA threatens clinical research. Ann Diagn Pathol. 2008 Oct;12(5):311-2
52. Sumaili EK, Cohen EP Screening for chronic kidney disease in sub-Saharan Africa. Lancet. 2010 Aug 7;376(9739):418
53. Moulder JE, Fish BL, Cohen EP, Klein JP Re: Davis et al., "Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation". Exp Hematol. 2011 May;39(5):521-2; author reply 522-4
54. Cohen EP, Krzesinski JM C-reactive protein and dialysis access. Kidney Int. 2009 Nov;76(10):1025-6
55. Cohen EP, Moulder JE Radiation risk to dialysis patients. Kidney Int. 2011 Mar;79(6):686
 
Abstracts
1. Cohen, E., Hanna, B., Holmes, B., et. al. Ceftizoxime therapy of serious infections; open and controlled trial. Presented at the 21st Interscience Conference on Antimicrobial Agents and Chemotherapy, November, 1981, Chicago, IL.
2. Cohen, E., Liu, K., Gutterman, C., Batlle, D. Acid-base patterns of metabolic acidosis in patients with end-stage renal disease: Impact of hemodialysis. Presented at the 16th Meeting of the National Kidney Foundation, Washington D.C., December 1986.
3. Cohen, E.P., Taylor, A.J., Erickson, S.J., Foley, M.D. and Piering, W.F. Screening for acquired cystic kidney disease: Comparison of CT and Ultrasound. Kidney Int. 35(1):191, 1989.
4. Cohen, E.P., Sheth KJ, Hunter JB, Casper JT, Ash RC. Association of HLA-B40/12 and cross-reactive group with post-bone marrow transplant hemolytic uremic syndrome. Kidney Int 37 (1): 438, 1990.
5. Elliott WC, Cohen EP, Taylor AJ. The role of ischemia in acquired cystic kidney disease. Kidney Int 37 (1): 505, 1990.
6. Cohen EP, Sievers SG, Piering WF. Differences in renal function at start of chronic dialysis in diabetics and non-diabetics. ASAIO Abstracts, p. 12, 36th Annual Meeting ASAIO, Washington D.C., 1990.
7. Lawton CA, Cohen EP, Barber-Derus SW, Murray KJ, Moulder JE, Ash RC, Casper JT, Wilson JF. Late renal dysfunction in adult survivors of bone marrow transplantation. Presentation to the American Radium Society, April, 1990.
8. Lawton CA, Moulder JE, Cohen EP, et al. Late renal dysfunction in survivors of bone-marrow transplantation: Human-animal correlations. 38th Annual Radiat. Res. Soc. 1990, p 113.
9. Cohen EP, Russell T, Garancis J. Mast cells and calcium in uremic itching. Clin. Res. 38(3):836A, 1990.
10. Cohen EP, Lawton CA, Ash RC, Moulder J, Hunter J. Clinical course of bone marrow transplant nephropathy (BMTNp). J. Am. Soc. Nephrol. 1 (4):289, 1990.
11. Brandes JC, Cohen EP. A rapid method for calculating urea kinetics: the 60 - 40 rule. Am J. Kidney Dis. 17(2); A3, 1991.
12. Sievers SG, Cohen EP, Stack J, Piering WF. Decreased re-use of hemodialysis membranes in diabetics compared to non-diabetics. ASAIO Abstracts, p 83, 37th Annual Meeting, Chicago, IL, 1991.
13. Sievers SG, Stack JL, Piering WF, Cohen EP. Determinants of dialyzer re-use. ISAO, 8th World Congress, Montreal, Canada, 1991.
14. Cohen EP, Fish BL, Moulder JE. Treatment of radiation nephritis with Captopril. Clin. Res. 39(3):771a, 1991.
15. Lawton CA, Ash RC, Murray KJ, Cohen EP, Barber-Derus SW, Moulder JE, Wilson JF. Influence of renal shielding on the incidence of late renal dysfunction associated with bone marrow transplantation. Radiology 181 (supplement):250, 1991.
16. Masi CM, Piering WF, Cohen EP. Dialysis efficacy and uremic itching. J. Am. Soc. Nephrol., 2 (3):338, 1991.
17. Cohen EP, Fish BL, Moulder JE. Use of captopril in prevention and treatment of radiation nephritis. Proc. 40th Annual Meeting Radiat. Res. Soc., 1992, p. 21.
18. Moulder JE, Cohen EP, Hill P, Fish BL. Treatment and prevention of bone marrow transplant nephropathy. ASTRO Proc., 1992.
19. Cohen EP, Piering WF, Taylor AJ. Evolution of polycystic kidney size during renal replacement therapy. Presentation to the 5th International Polycystic Kidney Research Foundation Meeting, Kansas City, MO, June 19, 1992.
20. Hill P, Moulder JE, Fish BL, Cohen EP. The effect of converting-enzyme inhibitors on experimental bone marrow transplant nephropathy. Clin. Res. 40:724A, 1992.
21. Cohen MR, Cohen EP. Transplantation arthritis: enthesopathies and sacroiliitis following kidney transplantation. Presentation to the 56th Annual meeting of the American College of Rheumatology, October 13, 1992.
22. Cohen EP, Moulder JE, Fish BL, Hill P. Prevention of experimental bone marrow transplant nephropathy. J. Am. Soc. Nephrol., 3:736, 1992.
23. Hill P, Cohen EP, Fish BL, Moulder JE. Antihypertensives in the prevention of bone marrow transplant nephropathy. Proc. 41st Annual Meeting, Radiat. Res. Soc. 1993.
24. Fish BL, Cohen EP, Hill P, Moulder JE. Captopril treatment of bone marrow transplant nephropathy as a function of duration of treatment. Proc. 41st Annual Meeting, Radiat. Res. Soc., 1993, p. 60.
25. Cohen EP, Moulder JE, Hill P, Fish BL. Treatment of radiation nephritis with ACE-inhibitors. Proc. 41st Annual Meeting, Radiat. Res. Soc., 1993, p. 60.
26. Stack J, Seiffert S, Piering WF, Cohen EP. Enhancing dialyzer reuse: the role of heparin technique. ASAIO Abstracts, p 78, 39th Annual Meeting, New Orleans, LA, 1993.
27. Taylor AJ, Cohen EP, Levine E, Grantham JJ. Etiology of non-cystic renal masses in the end-stage renal disease kidney. Presentation to the American Roentgen Ray Society, 1993 Meeting, San Francisco, CA.
28. Cohen EP, Fish BL, Moulder JE. Timing of captopril treatment for experimental bone marrow transplant nephropathy. Clin. Res. 41:677A, 1993.
29. Cohen EP, Fish BL, Moulder JE. Protective effect of brief captopril therapy in experimental bone marrow transplant nephropathy. J. Am. Soc. Nephrol. 4:767, 1993.
30. Cohen EP, Lawton CA, Moulder JE, Flomenberg N. Long-term survival with human bone marrow transplant nephropathy. J. Am. Soc. Nephrol. 4:273, 1993.
31. Cohen EP, Fish BL, Moulder JE. Dose-related beneficial effect of captopril in radiation nephropathy. J. Am. Soc. Nephrol.4:766, 1993.
32. Sarode R, McFarland JG, Flomenberg N, Casper JT, Cohen, EP, Drobyski W, Horowitz M, Camitta B, Garbrecht F, Pietryga D, Lawton C, Ash R, Gottschall J. Therapeutic plasma exchange not effective in the management of TTP/HUS following bone marrow transplantation. 35th Annual Meeting of the American Society of Hematology, St. Louis, MO, December 3, 1993.
33. Fish BL, Cohen EP, Moulder JE. Timing of captopril treatment for experimental bone marrow transplant nephropathy. Proc. 42nd Annual Mtg, Radiat. Res. Soc., 1994, p 210.
34. Cohen EP, Fish BL, Moulder JE. Urinary cyclic GMP as a marker of nitric oxide deficiency in radiation nephropathy. Proc. 42nd Annual meeting, Radiat. Res. Soc., 1994, p.211.
35. Cohen EP, Fish BL, Moulder JE. Determinants of therapeutic benefit of captopril in established radiation nephropathy. Clin. Res. 42:395A, 1994.
36. Jordan M, Cohen E., Bastani B., Roza A. H+ATPase in kidney transplant rejection. Clin. Res. 42:413A, 1994.
37. Cohen EP, Molteni A, Moulder J, Ward W, Fish B, Taylor J, Carone F. Captopril protective effect on radiation nephritis after bone marrow transplantation in rats. FASEB J:A844, 1995.
38. Cohen EP. Tissue mechanisms of radiation nephropathy. Proc Int'l Congr Radiat Res, Wurzburg, Germany, 1995.
39. Cohen EP, Whitehouse E, Hopewell J, Robbins MEC. Fibrotic narrowing of the tubular neck: possible role in progressive kidney failure. J. Am. Soc. Nephrol. 6:863, 1995.
40. Cohen EP, Norman JT, Fine LG, Fish BL, Moulder JE. Prevention of interstitial fibroblast activation in radiation nephritis. J. Am. Soc. Nephrol. 6:1011, 1995.
41. Fish BL, Cohen EP, Moulder JE. Renin angiotensin pathway is the key to radiation induced nephropathy. Proc. 44th Annual Meeting, Radiat. Res. Soc., 1996, p. 136.
42. Cohen EP, Juckett MB. Benefit of angiotensin antagonism in bone marrow transplant nephropathy. J. Am. Soc. Nephrol. 7:1370, 1996.
43. Lawton CA, Cohen EP, Rhoades JL, Murray KJ, Moulder JE. Influence of radiation dose and fractionation schedule on the incidence of clinical bone marrow transplant nephropathy. Proc. 45th Annual Mtg. Radiat. Res. Soc., 1997.
44. Cohen EP, Fish BL, Moulder JE. Reduction in late radiation scarring in a radiation nephropathy model. Proc. 45th Annual Mtg. Radiat. Res. Soc., 1997.
45. Fish BL, Cohen EP, Moulder JE. Comparison of the efficacy of captopril versus an AII receptor blocker on radiation nephropathy. Proc. 45th Annual Mtg. Radiat. Res. Soc., 1997.
46. Rhoades J, Lawton C, Cohen E, Murray K, Horowitz M, Drobyski W, Caspar J, and Moulder J. Incidence of Bone Marrow Transplant Nephropathy (BMT-Np) After Twice Daily BID Hyperfractionated Total Body Irradiation. Presented at the American Radium Society, April 30 - May 4, 1997.
47. Hariharan, S., McBride, M., Bennett, L., Cohen, E.P. Risk factors for allograft survival from older cadaver donors. American Society of Transplant Physicians, 16th Annual Meeting, Chicago, Illinois, May, 1997.
48. Robbins MEC, Bonsib SM, Hopewell JW, Whitehouse E, Cohen EP. Fibrosis in radiation nephropathy : mesangial activation, fibrin, and TGFß1. J Am Soc Nephrol, 8:526a, 1997.
49. Cohen EP, Fish BL, Moulder JE. Angiotensin II enhancement of radiation nephropathy. J Am Soc Nephrol, 8:612a, 1997.
50. Cohen EP, Kabler-Babbitt C, Piering WF, Moulder JE. End stage renal disease after marrow transplantation : higher mortality compared to other causes of ESRD. J Am Soc Nephrol, 8:135a, 1997.
51. Fish BL, Moulder JE, Cohen EP. Angiotensin II exacerbates radiation nephropathy. Proc 46th Annual Mtg. Radiat. Res. Soc., April, 1998, Louisville.
52. Butcher JA, Cohen EP, Adams MB, et al. Renal transplantation for ESRD following bone marrow transplantation : a report of 5 cases, with and without immunosuppression. Presented to the 17th annual meeting of the American Society for Transplant Physicians, Chicago, May, 1998.
53. Ahuja M, Piering WF, Cohen EP. Cocaine, hypertension, and compliance : single center hemodialysis experience. Am J Kidney Dis 33: A1, 1999.
54. Decker PA, Cohen EP, Ashley BA, et al. Subtotal parathyroidectomy in renal failure: still needed after all these years. International Society of Surgery, 1999 meeting, August 1999, Vienna Austria
55. Sharma M, Sharma R, McCarthy ET, Ge XL, Fish BL, Savin VJ, Cohen EP, Moulder JE. Early detection of radiation-induced glomerular injury by albumin permeability assay. J Am Soc Nephrol 10:115a, 1999.
56. Cohen EP, Salatnik L, Leach N, Ahuja M. Reduction of interdialytic weight gain: variable effect of low salt diet. J Am Soc Nephrol 10: 237a, 1999.
57. Ahuja M, Piering W, Cohen EP. Cocaine, hypertension, compliance, and survival on hemodialysis. J Am Soc Nephrol 10: 361a, 1999.
58. McMurray L, Gibson IW, Lindop GBM, MacKay I, Downie T, More IA, Fish BL, Moulder JE, Cohen EP. Atubular glomeruli in radiation nephropathy : a scanning electron microscopy study. J Am Soc Nephrol 10: 553a, 1999.
59. Ahuja M, Bresnahan BA, Cohen EP, Dayer A, Hariharan S. Polyoma virus infection in renal allografts : association with immunosuppression, acute rejection, CMV infection, and rapidly progressive allograft dysfunction. J Am Soc Nephrol 10: 752a, 1999
60. Cohen EP, Fish BL, Moulder JE. High sodium diet attenuates radiation nephropathy in rats. J Am Soc Nephrol 11:615a, 2000
61. Juckett M, Keever Taylor C, Klein J, Cohen EP. Loss of renal function following bone marrow transplantation : an anlysis of angiotensin converting enzyme polymorphism and other clinical risk factors. Blood 96 (suppl 1):394a, 2000
62. Cohen EP. Reduction of blood pressure by reduction of dialysate sodium. 21st Annual Dialysis Conference, 2001 annual mtg, New Orleans.
63. Hussain S, Bresnahan B, Cohen EP, Hariharan S. Rapid kidney allograft failure is associated with antilymphocyte therapy in patients with polyoma virus interstitial nephritis. Am J Transplant 1 (suppl 1): 271 a, 2001
64. Cohen EP, Rosendale JD, Haywood-Bong CJ, Hariharan S. The benefit of child to parent kidney donation : an analysis of UNOS data. Am J Transplant 1 (suppl 1): 250 a, 2001
65. McPhee TC, Gibson I, Balsillie A, Downie TT, More IAR, Cohen E, Lindop GBM. Radiation nephropathy in the rat : a model of tuft to capsule adhesions. J Pathol 193 (suppl) 43a, 2001
66. Cohen EP, Cooley CP, Chen SC. Reduction in parathyroidectomy by parenteral vitamin D: trends since 1988. J Invest Med, 2001
67. Cohen EP, Moulder JE, Fish BL. High salt diet attentuates radiation nephropathy. J Am Soc Nephrol , 12:811a, 2001
68. Cohen EP, Cooley CP, Chen SC. Declining Use of Parathyroidectomy and Use of Calcitriol: 1988-1998. J Am Soc Nephrol , 12:762a, 2001
69. Cohen EP. Survival and cost of home hemodialysis- is it worthwhile? J Am Soc Nephrol, 13: 400a, 2002
70. Cohen EP, Hussain SA, Moulder JE. Treatment of bone marrow transplant nephropathy byangiotensin converting enzyme inhibitors or angiotensin receptor blockers. J Am Soc Nephrol, 2002, 13: 673a, 2002
71. Sharma M, Sharma R, McCarthy ET, Fish, BL, Cohen EP, Moulder JE, Savin VJ. Low dose ionizing radiation induces immediate changes in glomerular function and signaling pathways. J Am Soc Nephrol, 13: 159a, 2002.
72. Kovaliv TB, Cohen EP. Fractionated versus standard heparin in the treatment of glomerulonephritis and secondary nephropathies: therapeutic implications. J Am Soc Nephrol, 13: 670a, 2002
73. Alausa MO, Rosendale J, Hariharan S, Cohen EP. Kidney transplants after a previous bone marrow transplant. Am J Kidney Dis, 2003, 41 (4): A13, 2003.
74. Cohen EP, Fish BL, Moulder JE. Angiotensin II type 2 blockade in radiation nephropathy. J Am Soc Nephrol, 14 : 412a, 2003
75. Cohen EP. Reduction in use of parathyroidectomy. J Am Soc Nephrol, 14: 684a. 2003
76. Cohen EP, Charba DS. Rising mortality on home hemodialysis. J Am Soc Nephrol, 14 : 245a,2003
77. Hariharan S, Hussain S, Orentas R, Cohen EP. BK viral DNA as guide to therapy. J Am Soc Nephrol, 14 : 43a, 2003
78. Hussain S, Orentas R, Walczak J, Cohen EP, Hariharan S. Prevention of BKV Nephritis by Monitoring BK Viremia in Renal Transplant Recipients - A Prospective Study. . American Transplant Congress 2004.
79. EP Cohen, M Joines and JE Moulder Prevention of clinical radiation nephropathy. Oral presentation to the 2004 Radiation Research Society meeting, St Louis MO April 2004
80. JE Moulder, BL Fish and EP Cohen Renal irradiation and angiotensin II receptors Poster presentation to the 2004 Radiation Research Society meeting, St Louis MO, April 2004
81. BL Fish, JE Moulder and EP Cohen Dietary sodium modification and experimental radiation nephropathy Poster presentation to the 2004 Radiation Research Society meeting, St Louis MO, April 2004
82. Cohen EP, Kobori H, Moulder JE, Fish BL, Navar LG. Intrarenal angiotensinogen expression in radiation nephropathy. 2005 Southern meeting of the American Federation for Medical Research, New Orleans, LA, Feb 24, 2005
83. Cohen EP, Fish BL, Moulder JE. Les bienfaits du sel: cas de la nephrite radique. 7ième Rèunion Commune de la Société de Néphrologie, Clermont-Ferrand, France, 2005.
84. Prosser SE, Jurgens LA, Orentas RJ, Cohen EP, Hariharan S. Analysis of the non-coding control region (NCCR) of BK Virus: demonstration of increased variability in BK nephritis patients with high viral load. J AM Soc Nephrol 16:89a, 2005
85. Prosser SE, Orentas RJ, Cohen EP, Hariharan S. Assessing anti-viral immunity to BK virus in patients with BK nephritis by ELISPOT. J Am Soc Nephrol, 16:229a, 2005
86. Sharma M, McCarthy ET, Sharma R, Fish BL, Cohen EP, Savin VJ, Moulder JE. Radiation induced early glomerular injury is mitigated by ibuprofen. J Am Soc Nephrol, 16:650a, 2005
87. Vasudev BS, Cohen E, Orentas R, DuChateau B, Hariharan S. Humoral immune recovery in BK virus nephritis: a prospective study. J Am Soc Nephrol, 16:704a, 2005
88. Cohen EP, Fish BL, Moulder JE. Mitigation of radiation nephropathy. J Invest Med 54
89. (suppl 2): S353, 2006
90. Sood P, Sinson GP, Cohen EP. Subdural hematomas in chronic dialysis patients: significant
91. and increasing. J Am Soc Nephrol, 17: 320a, 2006
92. Sood P, Zhu YR, Cohen EP. Death with functioning kidney transplant: an obituarial analysis.
93. J Am Soc Nephrol, 18: 435a, 2007
94. Sato M, Cohen EP, Hotta O, Taguma Y. Impact of atubular glomeruli as a contributing factor to progression in advanced IgA nephropathy. J. Am Soc. Nephrol., 2007, 18: 320a, 2007
95. Cohen EP, Fish BL, Irving A, Moulder JE. Aldosterone: A Key Effector in radiation nephropathy. J. Am Soc. Nephrol., 19 : 860a, 2008.
96. Sumaili EK, Zinga CV, Cohen EP, et al. High prevalence of undiagnosed chronic kidney disease in sub-saharan Africa: data from Kinshasa. J. Am. Soc. Nephrol., 19: 535a, 2008.
97. Cohen EP, Irving A, Moulder JE. Captopril improves survival and reduces occurrence of renal disease after bone marrow transplant. J. Am Soc. Nephrol., 2008, 19: 545a, 2008.
98. Cohen EP, Bruder ED, Jankowski B, Raff H. Pituitary adrenal function after total body irradiation: effect of head shielding. J Invest Med 58:671, 2010
99. Lenarczyk M, Moulder JE, Fish BL, Hessner M, Cohen EP. Renal gene expression profile in radiation nephropathy. J Am Soc Nephrol , 2010, in press